ACI-7104.056

· AC Immune SA

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ACI-7104.056, covering 2025-11-21 to 2025-11-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease [Phase 2]